You may soon be able to eat your Ozempic… sort of. GLP-1 supplements are booming, promising to deliver similar benefits to ...

Patients turned to compound versions, which were made by licensed pharmacists but were not FDA approved. Last year, around ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured and underinsured individuals to be able to pay cash for its weight ...

The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.

Novo Nordisk is cutting the price of its weight-loss drug, Wegovy, and selling it through a direct-to-patient online pharmacy ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

In Australia, Mounjaro, Wegovy and Saxenda (liraglutide) are approved for weight loss. People on these medications commonly ...

Under US Food and Drug Administration (FDA ... declared that shortages of Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy had ended. As a result, the availability of lower-cost, compounded ...

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to ...

With off-label use, a drug is prescribed for a use other than that approved by the Food and Drug Administration (FDA). The FDA has approved Wegovy and Mounjaro for the following uses in adults ...